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Summary 
 
 Our objective was to determine accuracy 
of identifying anovulatory lactating dairy 
cows before the application of a timed AI pro-
tocol [with or without progesterone supple-
mentation via a controlled internal drug re-
lease (CIDR) insert and 2 different timings of 
AI] by using heatmount detectors and a single 
ovarian ultrasound examination. At 6 Midwest 
locations, 1,072 cows were enrolled in a Pre-
synch protocol (2 injections of prostaglandin 
F2α (PGF2α) 14 days apart) with the second 
injection administered 14 days before initiat-
ing the Ovsynch protocol (injection of gonad-
otropin releasing hormone (GnRH) 7 days be-
fore and 48 hours after PGF2α injection, with 
timed AI at 0 or 24 hours after the second 
GnRH injection). Heatmount detectors were 
applied to cows at the time of the first Pre-
synch injection, assessed 14 days later at the 
second Presynch injection and again at initia-
tion of the Ovsynch protocol, and ovaries 
were examined for presence of a visible cor-
pus luteum (CL) by ultrasound before initia-
tion of treatment. Treatments were assigned to 
cows based on presence or absence of a visi-
ble CL: 1) anovulatory (no CL + CIDR insert 
for 7 d); 2) anovulatory (no CL + no CIDR); 
and 3) cycling (CL present). Further, every 
other cow in the 3 treatments was assigned to 
be inseminated concurrent with the second 
GnRH injection of Ovsynch (0 hour) or 24 
hours later. Pregnancy was diagnosed at 33 
and 61 days after the second GnRH injection. 
Heatmount detectors and a single ultrasound 
examination both underestimated proportions 
of cows classified as anovulatory or having no 
prior luteal activity compared with those clas-
sifications determined by concentrations of 
progesterone in blood serum.  Overall accu-
racy of heatmount detectors and ultrasound 
was 71 and 84%, respectively. Application of 
progesterone to cows without a CL at the time 
of the first injection of GnRH reduced inci-
dence of ovulation but improved pregnancy 
rates at day 33 or 61 compared with non-
treated cows without a CL at the onset of the 
Ovsynch protocol. Pregnancy rates and preg-
nancy survival did not differ for cows having 
a CL before treatment compared with those 
not having a CL but treated with progesterone. 
Pregnancy rates were 1.5-fold greater for cows 
ovulating in response to the first GnRH injec-
tion. Timing of AI at 0 or 24 hours after the 
second GnRH injection did not alter preg-
nancy rates, but cows having prior luteal ac-
tivity before treatment had improved preg-
nancy rates compared with anovulatory cows. 
We conclude that identifying anovulatory 
cows by ultrasound was more accurate than by 
heatmount detectors. Subsequent treatment of 
 
        
 
1Authors and their locations: Krisher (IN) Lamb, Larson, and Dahlen (MN), Pursley and Bello (MI), 
Fricke, Wiltbank, and Brusveen (WI), and Burkhart, Youngquist, and Garverick (MO). 
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potential anovulatory cows with progesterone 
failed to improve fertility but had benefit for 
cows with prior estrous cycles at the onset of 
the timed AI (TAI) protocol, regardless of 
luteal status before the final luteolytic injec-
tion of PGF2α. 
 
(Key words: anovulation, controlled internal 
drug release, Ovsynch, pregnancy rates.) 
 
Introduction 
 
 Because fertility of lactating dairy cows is 
poor and has decreased more than 50% since 
1970, improving fertility of lactating dairy 
cows is economically important to dairy pro-
ducers. A previous study examined effects of 
supplemental progesterone via a progesterone-
releasing, intravaginal CIDR insert in various 
experimental designs. Conception rates were 
greater for cows treated with progesterone 
during the Ovsynch protocol (injection of 
GnRH 7 days before and 48 hours after PGF2α 
injection, with TAI between 0 and 24 hours 
after the second GnRH injection) at 28 and 56 
days after TAI, respectively. In that study, 
conception rates were more positive for both 
cycling and noncycling or anovulatory cows 
treated with the CIDR insert compared with 
no CIDR treatment but only at 4 of the 6 loca-
tions at 28 days and at 3 of 6 locations at 56 
days after TAI. This inconsistent response is 
corroborated by other large-scale studies. 
 
 Estrus-detection aids including tail paint, 
chalk, and heatmount detectors are inexpen-
sive tools that may aid in the detection of non-
cycling cows before first AI. Likewise, ex-
amination of ovaries by transrectal palpation 
or ultrasonography is a means of identifying 
anovulatory cows that may benefit from pro-
gesterone supplementation as part of a TAI 
protocol. 
 
 Pregnancy rates are maximized when the 
TAI of the Ovsynch protocol is administered 
at 16 hours after the second GnRH injection. 
In practice, this timing is somewhat inconven-
ient and does not correspond to other man-
agement activities (e.g., AI, pregnancy diag-
nosis, vaccinations, and other treatments) that 
often occur while dairy cows are locked up at 
the feed line after morning milkings. Further, 
AI-pregnancy rates were not too different 
when AI occurred concurrent with the second 
GnRH injection or 24 hours later. 
 
The objectives of the present experiment 
were to determine: 1) accuracy of detecting 
anovulatory cows (no prior estrous cycles) by 
using heatmount detectors applied to cows 
during the 28 days before initiating the 
Ovsynch protocol or by a single ovarian ex-
amination employing transrectal ultrasonogra-
phy at the onset of the Ovsynch protocol; 2) 
benefit of applying progesterone (via a CIDR 
insert) during the first 7 days of the Ovsynch 
protocol; and 3) pregnancy rates after timing 
of AI occurred concurrent with the second 
GnRH injection of the Ovsynch protocol or 24 
hours later. 
 
Procedures 
 
Experimental Locations 
 This study was a collaborative project of 
the North Central Regional Research Project 
1006 of the Cooperative States Research, 
Education, and Extension Service (CSREES). 
Similar treatments were applied to lactating 
Holstein cows at 6 locations (Indiana, Kansas, 
Michigan, Minnesota, Missouri, and Wiscon-
sin) where co-authors were located. A total of 
1,072 cows were enrolled between April 2003 
and October 2005. A similar experimental de-
sign was used at each location. New cows 
were enrolled weekly or biweekly into breed-
ing clusters.  
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Experimental Protocol 
 Sampling, procedures, and design of 
treatments are illustrated (Figure 1). Cows 
were enrolled in a Presynch + Ovsynch proto-
col.  Two, 25-mg injections of PGF2α (5 mL 
of Lutalyse, Pfizer, New York, NY or 5 mL of 
Prostamate, Phoenix Scientific, Inc., St. Jo-
seph, MO) were given i.m. 14 days apart, and 
the Ovsynch protocol was initiated 14 days 
after the second Presynch injection with the 
first injection of GnRH. Prostaglandin F2α (25 
mg) was administered 7 days later and fol-
lowed in 48 hours by a second injection of 
GnRH. All injections of GnRH (100 μg) were 
administered i.m., consisting of 2 mL of Ova-
Cyst (Phoenix Scientific, Inc.). 
 
 Heatmount detectors (Kamar Inc., Steam-
boat Springs, CO) were affixed midline to the 
rump of each cow between the tail head and 
the tuber coxae (hook bones). Detectors were 
placed on all cows before the first Presynch 
injection and were assessed before the second 
Presynch and the first GnRH injection of 
Ovsynch. Condition of heatmount detector 
was recorded as red, absent, white, or partially 
red (leaky).  A new detector was applied be-
fore each injection if the detector was acti-
vated or absent. For purposes of this experi-
ment, sexual behavior associated with estrus 
was assumed to have occurred when the heat-
mount detector was activated or absent (ovula-
tory or cycling cows). Leaky or nonactivated 
detectors were assumed to be associated with 
no prior estrual activity (anovulatory or non-
cycling cows). 
 
Treatments 
 At the onset of the Ovsynch protocol, ova-
ries were examined by using transrectal ultra-
sonography. Ultrasonography was conducted 
by using a transrectal 5.0 or 7.5 MHz linear-
array transducer (Aloka 500V; Corometrics 
Medical Systems, Inc., Wallingford, CT). Fol-
licles and luteal structures were mapped, and 
follicles were sized by using internal calipers. 
Treatments were assigned to cows based on 
presence of a visible CL (CL absent vs. CL 
present): 1) anovulatory (no CL + CIDR insert 
for 7 d); 2) anovulatory (no CL + no CIDR); 
and 3) cycling (CL present). Further, every 
other cow within the 3 treatments was as-
signed to be inseminated concurrent with the 
second GnRH injection of Ovsynch (0 hour) 
or 24 hours later. Pregnancy was diagnosed at 
33 and 61 days after the second GnRH injec-
tion. Presence of fluid in the uterus, a CL, and 
a viable embryo were evidence of pregnancy. 
For cows that were pregnant at the first diag-
nosis (day 33), a subsequent ultrasound ex-
amination at day 61 was used to determine 
pregnancy loss. 
 
 At 3 locations (KS, MI, and MI), follicles 
also were mapped and sized at further ovarian 
exams performed by ultrasound before the 
PGF2α and second GnRH injections of 
Ovsynch  and at 5 days after the second GnRH 
injection to determine if ovulation occurred in 
response to the second GnRH injection. Blood 
was collected at all locations before each hor-
monal injection and again at 5 and 12 days 
after the second GnRH injection. Concentra-
tions of progesterone were measured to de-
termine prior luteal activity before and after 
treatments. 
 
Results and Discussion 
 
Location Characteristics 
 Various outcomes of lactating dairy cows 
treated at each of 6 locations are summarized 
in Table 1. A total of 1,072 cows were en-
rolled in the study in 6 Midwest states. Nearly 
all traits in Table 1 differed among locations, 
except for pregnancy rate at day 33. Calving 
difficulty scores averaged 1.3 ± 0.48 (SD) and 
ranged from 1.2 to 1.7. Average body condi-
tion score after calving and before the first 
Presynch injection (37 ± 7 DIM) were 2.8 ± 
0.48 (SD) and 2.6 ± 0.44 (SD), respectively. 
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Days in milk (DIM) at TAI averaged 75 ± 
7 (SD), with all cows first inseminated be-
tween 61 and 107 days (90% were insemi-
nated between 61 and 82 DIM). Pregnancy 
rates at days 33 and 61 averaged in the low to 
mid 30% range, with pregnancy loss averag-
ing 10.2%. Cows having prior luteal activity 
before treatment (65 ± 7 DIM), as assessed by 
concentrations of progesterone in 3 blood 
samples collected during 28 days before treat-
ment, averaged 83.7%. Regression of the CL 
in response to the PGF2α of the Ovsynch pro-
tocol averaged 88.5% across locations. 
 
Detection of Anovulatory Cows 
 Our first objective was to determine the 
accuracy of detecting anovulatory cows by 
means of heatmount detectors or a single ul-
trasound examination of ovarian structures in 
comparison with blood serum concentrations 
of progesterone. Both assessments were made 
at all 6 locations. Overall, relative to 3 blood 
serum concentrations assessed during 28 days 
before treatment, heatmount detectors and a 
single ultrasound exam of ovarian structures 
underestimated both anovulation and previous 
luteal or cycling activity. Relative to serum 
progesterone patterns, however, overall accu-
racy of heatmount detectors was 71.4% and 
that of a single ultrasound examination was 
84%. Ultrasound differed (P < 0.001) from 
heatmount detectors in every category except 
for apparent prevalence, including being more 
(P < 0.001) sensitive and specific than heat-
mount detectors, with the Kappa coefficient 
(0.52) in the good-agreement range compared 
with detectors (0.11). Heatmount detectors 
had greater (P < 0.001) rates of false positives 
(identifying incorrectly prior estrual activity 
and subsequent luteal activity) and false nega-
tives (missing prior estrual activity and subse-
quent luteal activity). 
 
Ovarian Characteristics in Response to Pro-
gesterone 
 Our second objective was to determine the 
effects of progesterone (CIDR insert) in cows 
identified with or without a CL at the onset of 
the Ovsynch protocol. This assessment was 
made by a single ultrasound examination of 
ovaries at all 6 locations, and as cited earlier, 
some cows were not correctly categorized by 
the single examination. Incidence of ovulation 
in response to the first GnRH injection was 
less (P < 0.05) in cows having no CL and 
treated with progesterone (CIDR insert) than 
in no CL cows not receiving a CIDR (Table 
2). Average incidence of ovulation was less  
(P < 0.001) for cows having a CL than for 
those without a CL (Table 2). Concentrations 
of progesterone for cows in the 3 previous 
classifications at onset of treatment were 0.7 ± 
0.2, 0.6 ± 0.2, and 4.0 ± 0.1 ng/mL, respec-
tively. 
 
Diameter of the ovulatory follicle, as-
sessed before the second GnRH injection, was 
smaller (P < 0.001) in cows with a CL present 
than for those with no CL, regardless of CIDR 
treatment (Table 2). Incidence of ovulation of 
that follicle, assessed 5 days later (after TAI), 
did not differ among cows having or not hav-
ing a CL (Table 2) at the onset of treatment. 
 
Fertility in Response to Progesterone 
 Pregnancy rates at days 33 and 61 and 
pregnancy loss in 1,068 cows (4 were culled 
before pregnancy diagnosis) during that inter-
val are summarized in Table 2 for all 6 loca-
tions.  Cows having a CL present at initiation 
of treatment had greater (P < 0.05) pregnancy 
rates at days 33 and 61 than those not having a 
CL . However, pregnancy rate at day 33 in CL 
absent cows treated with a CIDR did not differ 
from that in cows having a CL before treat-
ment but was greater than for CL absent cows 
not treated with a CIDR.  Cows requiring no 
calving assistance (calving difficulty score 
[CDS] = 1) subsequently had greater  
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(P < 0.05) pregnancy rates than those requir-
ing some (CDS > 1) assistance (42.7%; n = 
693 vs. 34.3%; n = 375), respectively. 
 
Pregnancy rates at day 61 followed the 
same pattern as those at day 33 (Table 2). 
Overall pregnancy loss was 10.4% and tended 
(P < 0.10) to be less in cows having a CL at 
the onset of treatment compared with cows not 
having a CL (Table 2). 
 
Time of Insemination 
 Our third objective was to determine 
whether time of AI relative to the second 
GnRH injection (0 vs. 24 hours) altered preg-
nancy rates (Table 3). The largest difference 
(5.4 percentage points in 24 hours) in preg-
nancy rate at day 33 for timing of AI was ob-
served in CL present cows. Otherwise, time of 
AI had no little effect on pregnancy outcome 
measured at day 33. Cows having a CL pre-
sent at treatment initiation had greater (P < 
0.05) pregnancy rates than CL absent cows 
not treated with a CIDR when inseminated at 
24 hours, but not 0 hours after the second 
GnRH injection. 
 
A CIDR treatment × location interaction 
tended (P = 0.085) to occur (Table 3) for 
pregnancy rates at day 33. Pregnancy rates for 
cows treated with a CIDR insert were greater 
at 4 locations than non-CIDR treated cows, 
but were less than non-CIDR treated cows at 
the other 2 locations. An interaction of loca-
tion × time of AI tended (P = 0.12) to occur, 
in which pregnancy rates for cows insemi-
nated at 0 hour were numerically greater at 3 
locations, but lesser at 3 other locations. Over-
all, pregnancy rates at 24 hours were numeri-
cally greater than those made at 0 hour 
(37.4%, n = 530 vs. 34%, n = 538), respec-
tively. 
 
Concentrations of Progesterone 
 The relationship of pretreatment cycling 
status and presence of high vs. low concentra-
tions of progesterone before the before injec-
tion of PGF2α injection of Ovsynch is exam-
ined further in Table 4. Because of the inaccu-
racy of identifying cycling status by ultra-
sound relative to blood concentrations of pro-
gesterone in these cows, 55.5% of 155 CL ab-
sent cows were truly not cycling and treated 
with a CIDR.  Further, 44% of 116 CL absent 
cows were truly not cycling and assigned to 
the no CIDR treatment.  These 2 groups of 
cows are designated by their pretreatment cy-
cling status in Table 4 
 
Effects of treatment of anovulatory cows 
based on serum concentrations of progester-
one are summarized in the top 3 lines of Table 
4, and treatment effects on previously cycling 
cows are summarized in the bottom 3 lines of 
Table 4. When only previously anovulatory 
cows were treated or not treated with a CIDR, 
their pregnancy rates did not differ from those 
in CL present cows regardless of progesterone 
concentrations at the time of the PGF2α injec-
tion (Table 4). In contrast, regardless of pro-
gesterone concentrations at the time of the 
PGF2α injection, CL absent cows treated with 
a CIDR and CL cows had greater pregnancy 
rates than the CL absent cows not treated with 
a CIDR (Table 4). Overall, cows having prior 
cycling activity, assessed by blood progester-
one before treatment, had 53% greater (P < 
0.001) pregnancy rates at day 33 than those 
without prior luteal activity (37.8 vs. 24.7%; 
Table 4). 
 
Treatment with the CIDR insert in a previ-
ous study improved pregnancy rates in cows 
that were previously noncycling without a 
functional CL before the PGF2α injection, but 
not in the present study (Table 4). Further, 
CIDR treatment in previously cycling cows 
having low concentrations of progesterone 
before PGF2α injection (early CL regression) 
had numerically greater pregnancy rates in the 
present study as in a previous study. Interpre-
tation of the results in the previous study indi-
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cated that the CIDR insert would improve 
conception rates in cows having no active CL 
or low progesterone before PGF2α injection 
regardless of previously cycling or luteal 
status, whereas in the present study, we could 
only verify improved fertility for previously 
cycling cows having low progesterone (early 
CL regression). Although interpretation of re-
sults in the present study relative to luteal 
status before PGF2α injection should be con-
servative because luteal status was con-
founded with CIDR-supplemented progester-
one concentrations, nearly 26% of the CL ab-
sent cows treated with a CIDR had concentra-
tions of progesterone < 1 ng/mL when the in-
sert was removed. Clearly, these cows had no 
CL at this time. Concentrations of progester-
one in cows bearing a luteal structure are gen-
erally not different before and after the insert 
is removed. 
 
Concentrations of progesterone in blood 
serum 2 days before the second GnRH injec-
tion (day of PGF2α injection of Ovsynch and 
removal of CIDR inserts), before the second 
GnRH injection, and 5 and 12 days later are 
illustrated in Figure 2.  At insert removal, 
cows treated with CIDR inserts had concentra-
tions of progesterone that did not differ from 
those in cows without inserts, but both treat-
ments had less (P < 0.05) progesterone than in 
CL present cows.  This same pattern existed 
48 hours later when the second GnRH injec-
tion was given (0 h). At 5 days after AI, no 
differences in progesterone concentration 
were detected among treatments, but at 12 
days after the second GnRH injection or 11 to 
12 days after AI, CL absent cows, regardless 
of CIDR treatment, had greater (P < 0.05) 
concentrations of progesterone than CL pre-
sent cows. The greater progesterone 12 days 
later is consistent with an earlier report in 
which cows treated with CIDR inserts during 
the Ovsynch protocol had greater progesterone 
concentrations than controls. It seems that ma-
turing follicles exposed to progesterone during 
CIDR treatment may, after ovulation, differen-
tiate into CL having greater progesterone  
secretory capacity. 
 
As expected, pregnancy status had no ef-
fect on concentrations of progesterone at 5 
days after the second GnRH injection, but at 
12 days, pregnant cows had greater (P < 
0.001) concentrations of progesterone than 
nonpregnant cows (4.7 ± 0.2; n = 686 vs. 3.6 ± 
0.1 ng/mL; n = 381). 
 
In summary, identifying cows with a CL 
was more accurate after the single ultrasound 
examination than during the 28 days when 
heatmount detectors were applied to cows. 
When lactating dairy cows were found to have 
no CL (but had evidence of increased concen-
trations of progesterone in blood serum during 
28 days before initiating the Ovsynch proto-
col) at the onset of the Ovsynch protocol and 
treated with progesterone (via a CIDR), preg-
nancy rates were greater than similar CL ab-
sent cows not treated with a CIDR. Pregnancy 
rates of the former did not differ from cows 
having a CL at the initiation of the TAI proto-
col. Our study finds no evidence that includ-
ing progesterone in a TAI protocol for previ-
ously noncycling cows is warranted, regard-
less of luteal status before the PGF2α injection 
of the Ovsynch protocol. Insemination of 
cows at 0 vs. 24 hours after the second GnRH 
injection did not differ significantly, even 
though a numerical advantage (5.4 percentage 
points) occurred for CL present cows insemi-
nated at 24 vs. 0 hours. 
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Table 1.  Selected Outcomes of Lactating Dairy Cows Enrolled at Each Location 
 Location 
Item IN KS MI MN MO WI Total
Cows enrolled, no. 80 217 153 194 242 186 1,072
Calving difficulty score1 1.5a 1.3a,b 1.2c 1.7d 1.4a 1.3b,c 1.3**
Body condition score post-calving1 2.9a 2.6b 2.7c 3.1d 2.9a … 2.8**
Body condition score at Presynch1,2 … 2.3a 2.4b 2.8c 2.7d 2.9c 2.6**
Days postpartum at first AI3 72a 79b 82c 69d 75e 72a 75**
Pregnancy rate at 33 d4, % 37.5 42.9 36.0 29.4 33.1 36.3 35.7
Pregnancy rate at 61 d4, % 37.5a 37.3a 33.3a 22.7b 29.8a,b 35.2a 32.0*
Pregnancy loss (33 to 61 d), % 0.0a,c 12.9b 7.3a,c 22.8b 10.0c 3.0c 10.2*
Luteal activity before treament5, % 92.5a 91.2a 89.5a 69.1b 79.3c 87.3a,c 83.7**
Regression of CL6, % 88.4a,b 86.7b,c 87.4b 81.9b 94.8a 90.6a,c 88.5**
**Location effect (P < 0.01). 
*Location effect (P < 0.05). 
a,b,c,d,eLocation values having different superscript letters differ (P ≤ 0.05). 
1Range of 1 to 5. Standard deviations ranged from 0.44 to 0.48. 
2Assessed before first Presynch PGF2α injection. 
3Standard deviation was 7.0. 
  4Determined by transrectal ultrasonography after the first postpartum AI. 
5Based on progesterone concentrations measured in a total of 3 blood samples collected be-
fore each Presynch PGF2α injection and before ultrasonography at the time of the first GnRH in-
jection of the Ovsynch protocol. Cutoff values for luteal activity were based on progesterone ≥ 1 
ng/mL and < 1 ng/mL for no luteal activity. 
6Cows having elevated concentrations of progesterone 48 to 72 hours before AI in which 
blood progesterone was < 1 ng/mL at 48 hours after the PGF2α injection of the Ovsynch proto-
col. 
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Table 2.  Ovarian Characteristics and Fertility in Response to Presence or Absence of a 
Corpus Luteum (CL) Assessed by Transrectal Ultrasonography and Progesterone Treat-
ment (CIDR insert) at the Onset of the Ovsynch Protocol 
 CL absent1 
Item No CIDR CIDR CL present1 
Ovulation after first GnRH2, % (no.) 76.8a (69) 47.1b (104) 43.4c,x (604) 
Presence of CL before PGF2α2, % (no.) 76.8a (69) 51.0b (104) 95.7c,x (610) 
Corpus luteum before PGF2α3 0.9a ± 0.1 (55)4 0.7a ± 0.1(78) 1.4b ± 0.1 (450)
 
Diameter of ovulatory follicle before sec-
ond GnRH2, mm 
16.7a ± 0.4 
(65)4 
16.2a ± 0.4 
(103) 
15.2b,x ± 0.1 
(588) 
Ovulation after second GnRH2, % (no.) 77.9 (68) 75.0 (104) 80.7 (605) 
Pregnancy rate at day 33, % (no.) 24.1a (116) 32.3b (155) 38.0b,x (797) 
Pregnancy rate at day 61, % (no.) 20.7a (116) 29.0b (155) 34.3b,x (797) 
Pregnancy loss from day 33 to 61, % (no.) 14.3 (28) 10.0 (50) 9.9y (303) 
 a,b,cMeans having different superscript letters differ (P ≤ 0.05). 
 xDifferent (P ≤ 0.05) from CL absent cows. 
 yTended (P ≤ 0.10) to differ from CL absent cows. 
1Absence or presence of a CL assessed by transrectal ultrasonography at the first GnRH in-
jection of the Ovsynch protocol. 
2Assessed at only 3 of 6 locations. 
3Assessed at only 2 of 6 locations. 
 4Mean ± SE and number of observations. 
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Table 3.  Pregnancy Rates at Day 33 After Timed Insemination on the Basis of Time of AI 
After the Second GnRH Injection and Location 
 CL absent1  
Item No CIDR CIDR CL present1 Overall 
AI time, hour after second GnRH -------------------- % (no.) -------------------- 
     0 
     24 
24.1a (54) 
24.2a (62) 
33.8a (74) 
30.9a (81) 
35.4a (401) 
40.8b,x (395) 
34.0 (530) 
37.4 (538) 
Location2 
     IN 
     KS 
     MI 
     MN 
     MO 
     WI 
 
22.2 (9) 
21.7 (23) 
12.5 (16) 
21.6 (37) 
35.0 (20) 
36.4 (11) 
 
18.8 (16) 
26.1 (23) 
58.3 (12) 
32.4 (34) 
29.0 (62) 
62.5 (8) 
 
45.5 (55) 
48.0 (171) 
36.8 (125) 
30.9 (123) 
34.4 (160) 
35.2 (162) 
37.5 (80) 
42.9 (217) 
35.9 (153) 
29.4 (194) 
33.1 (242) 
36.3 (182) 
 a,bMeans within AI timing having different superscript letters differ (P ≤ 0.05). 
 xDifferent (P ≤ 0.05) from corpus luteum (CL) absent cows at 24 hours. 
1Absence or presence of a CL assessed by transrectal ultrasonography at the first GnRH in-
jection of the Ovsynch protocol. 
2Interaction (P = 0.08) of treatment × location. 
 
 
 
Table 4.  Pregnancy Rates at Day 33 After Timed Insemination According to Luteal 
Activity Before Treatment and Concentrations of Progesterone at the Time of PGF2α
Injection 
  
CL absent3 Pretreatment 
cycling status1 
Serum 
progesterone 
before 
PGF2α2 No CIDR CIDR CL present3 
Pretreatment 
cycling total 
  ----------------------------- % (no.) ----------------------------- 
Noncycling High 29.4 (34) 32.1 (56) 32.0a,b (25)  
 
Low 
Total 
17.6 (17) 
25.4a (51) 
6.7 (30) 
23.3a (86) 
16.7a,x (12) 
27.0a (37) 
 
24.7 (174) 
 
Cycling High 25.9 (54) 44.1 (59) 40.2b (651)  
 
Low 
Total 
9.1 (11) 
23.1a (65) 
40.0 (10) 
43.5b(69) 
28.7a,b (108) 
42.8b(759) 
 
37.8* (893) 
a,bTreatment × cycling status interaction (P = 0.08). 
*Differed (P < 0.05) from noncycling cows. 
1 Based on progesterone concentrations measured in 3 blood serum samples collected before 
each Presynch PGF2α injection and before the first GnRH injection of the Ovsynch protocol. 
2 Low = concentrations of progesterone < 1 ng/mL, and high = ≥ 1 ng/mL.  
3 Absence or presence of a corpus luteum (CL) assessed by transrectal ultrasonography at the 
first GnRH injection of the Ovsynch protocol. Some CIDR-treated cows may have had elevated 
progesterone because of the CIDR insert. 
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Figure 1.  Experimental Protocol Showing Design of Treatments.  Heatmount detectors (K) 
were applied to detect mounted activity. Activated heatmount detectors were replaced at each 
evaluation. Blood (B) was collected before various injections and twice post AI. Presence of a 
corpus luteum (CL) was detected by transrectal ultrasonography (US) and, alternatively, cows 
without a CL received a progesterone-releasing intravaginal controlled internal drug release 
(CIDR) insert.  Cows having a CL present received no CIDR. All cows received GnRH at 48 
hours after PGF2α (PGF) and were inseminated before the second GnRH injection (0 hour) or 24 
hours later in the 3 treatments. Pregnancy was diagnosed at 33 days after timed AI and recon-
firmed at 61 days after timed AI. 
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Figure 2.  Concentrations of Progesterone in Serum of Lactating Dairy Cows Before Injec-
tions of PGF2α [time of progesterone (CIDR) Insert Removal; day −2] and the Second 
GnRH Injection (day 0), and at 5 and 12 Days After GnRH.  a,b Means having different su-
perscript letters differ (P < 0.05). 
